Indefinite Delivery Contract SPE2DU25D9439

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $499,999,999 single-award IDC enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The contract was not set aside and covers various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. It is part of DLA's Pharmaceutical Prime Vendor Global Program Generation V, a $30.3 billion unrestricted and fully competitive acquisition to establish multiple regional contracts for worldwide pharmaceutical support to DoD customers, the U.S. Coast Guard, and other government agencies. The contract has a 30-month base period and three 30-month option periods, running through November 2026. This IDC positions DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.